Sunshine Heart Inc Debt to Equity Ratio 2011-2018 | CHFS

Current and historical debt to equity ratio values for Sunshine Heart Inc (CHFS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Sunshine Heart Inc debt/equity for the three months ending September 30, 2018 was 0.00.
Sunshine Heart Inc Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.00B $0.01B 0.00
2018-06-30 $0.00B $0.01B 0.00
2018-03-31 $0.00B $0.01B 0.00
2017-12-31 $0.00B $0.02B 0.00
2017-09-30 $0.00B $0.01B 0.00
2017-06-30 $0.00B $0.01B 0.00
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.00B $0.00B 0.00
2016-09-30 $0.00B $0.00B 0.00
2016-06-30 $0.00B $0.00B 0.53
2016-03-31 $0.00B $0.01B 0.39
2015-12-31 $0.00B $0.01B 0.32
2015-09-30 $0.01B $0.02B 0.27
2015-06-30 $0.01B $0.03B 0.24
2015-03-31 $0.01B $0.03B 0.17
2014-12-31 $0.00B $0.03B 0.00
2014-09-30 $0.00B $0.04B 0.00
2014-06-30 $0.00B $0.04B 0.00
2014-03-31 $0.00B $0.05B 0.00
2013-12-31 $0.00B $0.05B 0.00
2013-09-30 $0.00B $0.06B 0.00
2013-06-30 $0.00B $0.02B 0.00
2013-03-31 $0.00B $0.01B 0.00
2012-12-31 $0.00B $0.01B 0.00
2012-09-30 $0.00B $0.02B 0.00
2012-06-30 $0.00B $0.00B 0.00
2012-03-31 $0.00B $0.00B 0.00
2011-12-31 $0.00B $0.01B 0.00
2011-09-30 $0.00B $0.00B 0.00
2011-06-30 $0.00B $0.00B 0.00
2011-03-31 $0.00B $0.00B 0.00
2010-12-31 $0.00B $0.01B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.005B $0.004B
CHF Solutions, Inc. is a medical device company which focused on commercializing the Aquadex FlexFlow (R) System. Its commercial product Aquadex system, is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. CHF Solutions Inc., formerly known as Sunshine Heart Inc., is headquartered in Minneapolis.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $95.882B 22.34
Intuitive Surgical (ISRG) United States $61.015B 60.03
Edwards Lifesciences (EW) United States $33.262B 35.60
Fresenius Medical Care AG KGaA (FMS) Germany $21.393B 14.47
IDEXX Laboratories (IDXX) United States $16.979B 48.50
ABIOMED (ABMD) United States $14.877B 106.90
DexCom (DXCM) United States $13.282B 0.00
Hologic (HOLX) United States $12.465B 19.24
Teleflex (TFX) United States $11.712B 26.59
Varian Medical Systems (VAR) United States $11.485B 28.58
STERIS (STE) United Kingdom $9.519B 25.26
Masimo (MASI) United States $6.241B 40.47
Penumbra (PEN) United States $4.777B 288.42
LivaNova (LIVN) United Kingdom $4.482B 28.77
Globus Medical (GMED) United States $4.227B 26.49
Integra LifeSciences Holdings (IART) United States $3.949B 19.24
Wright Medical Group (WMGI) Netherlands $3.555B 0.00
Cantel Medical (CMD) United States $3.248B 32.04
Inogen (INGN) United States $3.171B 68.45
Integer Holdings (ITGR) United States $2.645B 22.14
Tandem Diabetes Care (TNDM) United States $2.541B 0.00
Glaukos (GKOS) United States $2.178B 0.00
Halyard Health (AVNS) United States $2.151B 19.39
OPKO Health (OPK) United States $2.083B 0.00
Nevro (NVRO) United States $1.328B 0.00
Luminex (LMNX) United States $1.166B 42.19
Tactile Systems Technology (TCMD) United States $1.152B 183.38
Natus Medical (BABY) United States $1.135B 23.84
Pacific Biosciences Of California (PACB) United States $1.089B 0.00
CryoLife (CRY) United States $1.065B 92.93
Orthofix (OFIX) United States $0.969B 27.97
Accelerate Diagnostics (AXDX) United States $0.883B 0.00
Intersect ENT (XENT) United States $0.879B 0.00
Mesa Laboratories (MLAB) United States $0.832B 49.21
AngioDynamics (ANGO) United States $0.778B 25.25
ViewRay (VRAY) United States $0.724B 0.00
Veracyte (VCYT) United States $0.663B 0.00
TransEnterix (TRXC) United States $0.616B 0.00
AxoGen (AXGN) United States $0.589B 0.00
Si-Bone (SIBN) United States $0.544B 0.00
OrthoPediatrics (KIDS) United States $0.429B 0.00
Quotient (QTNT) Switzerland $0.399B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.394B 0.00
Sientra (SIEN) United States $0.378B 0.00
Fluidigm (FLDM) United States $0.340B 0.00
GenMark Diagnostics (GNMK) United States $0.333B 0.00
Accuray (ARAY) United States $0.333B 0.00
SeaSpine Holdings (SPNE) United States $0.288B 0.00
IRadimed (IRMD) United States $0.279B 72.77
RTI Surgical (RTIX) United States $0.274B 43.20
Neuronetics (STIM) United States $0.259B 0.00
Nuvectra (NVTR) United States $0.256B 0.00
Pulse Biosciences (PLSE) United States $0.247B 0.00
CRH Medical (CRHM) Canada $0.228B 39.25
Corindus Vascular Robotics (CVRS) United States $0.224B 0.00
Helius Medical Technologies (HSDT) United States $0.212B 0.00
T2 Biosystems (TTOO) United States $0.163B 0.00
Sensus Healthcare (SRTS) United States $0.132B 0.00
Ra Medical Systems (RMED) United States $0.114B 0.00
Ekso Bionics Holdings (EKSO) United States $0.104B 0.00
Alphatec Holdings (ATEC) United States $0.077B 0.00
Biosig Technologies (BSGM) United States $0.074B 0.00
EDAP TMS (EDAP) France $0.073B 0.00
Apollo Endosurgery (APEN) United States $0.071B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.064B 0.00
Second Sight Medical Products (EYES) United States $0.061B 0.00
Vermillion (VRML) United States $0.055B 0.00
Titan Medical (TMDI) Canada $0.045B 0.00
Electromed (ELMD) United States $0.042B 20.32
OBALON THERPTCS (OBLN) United States $0.039B 0.00
Viveve Medical (VIVE) United States $0.037B 0.00
ConforMIS (CFMS) United States $0.034B 0.00
Restoration Robotics (HAIR) United States $0.034B 0.00
Microbot Medical (MBOT) United States $0.030B 0.00
Xtant Medical Holdings (XTNT) United States $0.029B 0.00
PAVmed (PAVM) United States $0.025B 0.00
Lianluo Smart (LLIT) China $0.024B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.024B 0.00
Dynatronics (DYNT) United States $0.022B 0.00
Neovasc (NVCN) Canada $0.021B 0.00
DarioHealth (DRIO) Israel $0.020B 0.00
American Shared Hospital Services (AMS) United States $0.015B 11.22
Bioanalytical Systems (BASI) United States $0.014B 67.50
Nanovibronix (NAOV) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Presbia (LENS) Ireland $0.010B 0.00
ReWalk Robotics (RWLK) Israel $0.009B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Avinger (AVGR) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.006B 0.00
Amedica (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00